Latest / US News Today | 2 Min News | The Daily News Now!
GLP-1 Drugs Surge in U.S. Obesity Fight | US News
Gallup’s latest data reveals a dramatic spike in U.S. adults using weight-loss GLP-1 drugs—now 11% of the population, up from just 3% a few years ago. These meds, including Ozempic and Wegovy, have become household names, with 91% of Americans aware of them and 15% having tried one. The surge coincides with a drop in national obesity rates and stabilized diabetes levels, suggesting real health impact. While brand-name drugs still dominate, 19% are opting for cheaper compounded versions due to cost or insurance issues—despite FDA warnings. Most users, regardless of version, report strong…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.